1.This assay is intended for detecting ROS1 gene rearrangement status in human non-small cell lung cancer to guide targeted therapy with crizotinib.
2.ROS1 is frequently overexpressed in various cancers including lung cancer, breast cancer, and liver cancer, and often undergoes reciprocal translocation with other genes in non-small cell lung cancer.